BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 10561653)

  • 1. The capture rate of at-risk term newborns for early-onset group B streptococcal sepsis determined by a risk factor approach.
    Towers CV; Suriano K; Asrat T
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1243-9. PubMed ID: 10561653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of intrapartum maternal risk factors for identifying neonates at risk for early-onset group B streptococcal sepsis: A prospective study.
    Towers CV; Rumney PJ; Minkiewicz SF; Asrat T
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1197-202. PubMed ID: 10561645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
    Verani JR; McGee L; Schrag SJ;
    MMWR Recomm Rep; 2010 Nov; 59(RR-10):1-36. PubMed ID: 21088663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention of early-onset neonatal group B streptococcal disease.
    Money D; Allen VM;
    J Obstet Gynaecol Can; 2013 Oct; 35(10):939-948. PubMed ID: 24165063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of fever in labor and risk of neonatal sepsis.
    Towers CV; Yates A; Zite N; Smith C; Chernicky L; Howard B
    Am J Obstet Gynecol; 2017 Jun; 216(6):596.e1-596.e5. PubMed ID: 28216060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care.
    Mercer BM; Ramsey RD; Sibai BM
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):842-6. PubMed ID: 7573255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797.
    Obstet Gynecol; 2020 Feb; 135(2):e51-e72. PubMed ID: 31977795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion Summary, Number 797.
    Obstet Gynecol; 2020 Feb; 135(2):489-492. PubMed ID: 31977793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review.
    Illuzzi JL; Bracken MB
    Obstet Gynecol; 2006 Nov; 108(5):1254-65. PubMed ID: 17077253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and adverse effects of group B streptococcal colonization during pregnancy.
    Namavar Jahromi B; Poorarian S; Poorbarfehee S
    Arch Iran Med; 2008 Nov; 11(6):654-7. PubMed ID: 18976037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of universal antenatal screening for group B streptococcus.
    Van Dyke MK; Phares CR; Lynfield R; Thomas AR; Arnold KE; Craig AS; Mohle-Boetani J; Gershman K; Schaffner W; Petit S; Zansky SM; Morin CA; Spina NL; Wymore K; Harrison LH; Shutt KA; Bareta J; Bulens SN; Zell ER; Schuchat A; Schrag SJ
    N Engl J Med; 2009 Jun; 360(25):2626-36. PubMed ID: 19535801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy.
    Velaphi S; Siegel JD; Wendel GD; Cushion N; Eid WM; Sánchez PJ
    Pediatrics; 2003 Mar; 111(3):541-7. PubMed ID: 12612234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine culture-based screening versus risk-based management for the prevention of early-onset group B streptococcus disease in the neonate: a systematic review.
    Kurz E; Davis D
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):206-46. PubMed ID: 26447057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
    Pinto NM; Soskolne EI; Pearlman MD; Faix RG
    J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn.
    Ottolini MC; Lundgren K; Mirkinson LJ; Cason S; Ottolini MG
    Pediatr Infect Dis J; 2003 May; 22(5):430-4. PubMed ID: 12792384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of perinatal group B streptococcal disease: updated CDC guideline.
    Cagno CK; Pettit JM; Weiss BD
    Am Fam Physician; 2012 Jul; 86(1):59-65. PubMed ID: 22962913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do we need a different approach to GBS screening?].
    Szymusik I; Kosińska-Kaczyińska K; Pietrzak B; Wielgoś M
    Ginekol Pol; 2014 Jun; 85(6):456-60. PubMed ID: 25029812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review.
    Benitz WE; Gould JB; Druzin ML
    Pediatrics; 1999 Jun; 103(6):e77. PubMed ID: 10353974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapartum antibiotics for prolonged rupture of membranes at term to prevent Group B Streptococcal sepsis.
    Geethanath RM; Ahmed I; Abu-Harb M; Onwuneme C; McGarry K; Hinshaw K
    J Obstet Gynaecol; 2019 Jul; 39(5):619-622. PubMed ID: 30917724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of group B streptococcal infection.
    Noya FJ; Baker CJ
    Infect Dis Clin North Am; 1992 Mar; 6(1):41-55. PubMed ID: 1578122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.